• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞尿激酶型纤溶酶原激活物受体和 PSGL1 在体内动脉纤溶中发挥作用。

Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis.

机构信息

Henderson Research Centre and McMaster University, Hamilton, Ontario, Canada.

出版信息

Thromb Haemost. 2009 Dec;102(6):1212-8. doi: 10.1160/TH09-01-0038.

DOI:10.1160/TH09-01-0038
PMID:19967153
Abstract

Fibrin is an integral component of arterial thrombi. Using a mouse model of arteriolar thrombosis, high-speed fluorescence microscopy reveals that, within minutes, the fibrin content of thrombi rapidly increases and then decreases. The decrease in fibrin coincides with leukocyte binding to the thrombi, a process mediated by the interaction of leukocyte P-selectin glycoprotein ligand-1 (PSGL-1) with P-selectin on the surface of activated platelets. Because leukocytes possess urokinase-type plasminogen activator (uPA) activity, we used mice deficient in uPA or the uPA receptor (uPAR) to explore the contribution of leukocyte-associated uPA to the loss of fibrin from these thrombi. Fibrin loss in both uPA-deficient mice and uPAR-deficient mice was reduced compared with that in wild-type controls. Transfusion of leukocytes from wild-type mice into uPAR-deficient mice restored fibrin loss to levels similar to that in wild-type mice. In contrast, transfusion of leukocytes from mice deficient in uPAR or PSGL-1 did not enhance fibrin loss. Thus, fibrin loss from microarteriolar thrombi is mediated, at least in part, by leukocyte-associated uPA in a process that requires leukocyte uPAR and PSGL-1.

摘要

纤维蛋白是动脉血栓的重要组成部分。利用小鼠小动脉血栓形成模型,高速荧光显微镜显示,血栓中的纤维蛋白含量在数分钟内迅速增加,然后减少。纤维蛋白的减少与白细胞与血栓结合的过程相吻合,这个过程是由白细胞 P 选择素糖蛋白配体 1(PSGL-1)与激活血小板表面的 P 选择素相互作用介导的。由于白细胞具有尿激酶型纤溶酶原激活物(uPA)活性,我们使用缺乏 uPA 或 uPA 受体(uPAR)的小鼠来探索白细胞相关 uPA 对这些血栓中纤维蛋白丢失的贡献。与野生型对照相比,uPA 缺陷型小鼠和 uPAR 缺陷型小鼠的纤维蛋白丢失减少。将来自野生型小鼠的白细胞输注到 uPAR 缺陷型小鼠中,可将纤维蛋白丢失恢复到类似于野生型小鼠的水平。相比之下,输注缺乏 uPAR 或 PSGL-1 的小鼠的白细胞并不能增强纤维蛋白的丢失。因此,微动脉血栓中纤维蛋白的丢失至少部分是由白细胞相关的 uPA 介导的,该过程需要白细胞 uPAR 和 PSGL-1。

相似文献

1
Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis.白细胞尿激酶型纤溶酶原激活物受体和 PSGL1 在体内动脉纤溶中发挥作用。
Thromb Haemost. 2009 Dec;102(6):1212-8. doi: 10.1160/TH09-01-0038.
2
Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro.尿激酶缺陷型和尿激酶受体缺陷型小鼠在体外的中性粒细胞抗菌激活功能受损。
J Leukoc Biol. 2004 Sep;76(3):648-56. doi: 10.1189/jlb.0104023. Epub 2004 Jul 7.
3
Urokinase-type plasminogen activator receptor regulates leukocyte recruitment during experimental pneumococcal meningitis.尿激酶型纤溶酶原激活物受体在实验性肺炎球菌性脑膜炎期间调节白细胞募集。
J Infect Dis. 2005 Mar 1;191(5):776-82. doi: 10.1086/427829. Epub 2005 Jan 25.
4
Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.急性和慢性乙型肝炎患者血浆尿激酶型纤溶酶原激活剂及尿激酶型纤溶酶原激活剂受体的评估
Thromb Res. 2009;123(3):537-42. doi: 10.1016/j.thromres.2008.06.013. Epub 2008 Aug 8.
5
Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis.尿激酶型纤溶酶原激活剂在动脉生成过程中的非受体依赖性作用。
FASEB J. 2003 Jun;17(9):1174-6. doi: 10.1096/fj.02-0800fje. Epub 2003 Apr 8.
6
Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).环[19,31][D-半胱氨酸19]-尿激酶型纤溶酶原激活剂19-31是尿激酶型纤溶酶原激活剂与其受体(CD87)相互作用的强效竞争性拮抗剂。
Biol Chem. 2001 Aug;382(8):1197-205. doi: 10.1515/BC.2001.150.
7
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.尿激酶型纤溶酶原激活物受体(uPAR)在血液和骨髓细胞上的结构、功能及表达
Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398.
8
Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.尿激酶型纤溶酶原激活物受体促进巨噬细胞浸润到载脂蛋白E缺陷小鼠的血管壁中。
J Cell Physiol. 2005 Jul;204(1):73-82. doi: 10.1002/jcp.20262.
9
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.急性肺损伤中的凝血、纤维蛋白溶解及纤维蛋白沉积
Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. doi: 10.1097/01.CCM.0000057846.21303.AB.
10
Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.尿激酶受体缺陷型肾成纤维细胞的促有丝分裂信号传导:一种替代性尿激酶受体和低密度脂蛋白受体相关蛋白的作用
J Am Soc Nephrol. 2004 Aug;15(8):2090-102. doi: 10.1097/01.ASN.0000135057.41526.2C.

引用本文的文献

1
The fibrinolytic system enables the onset of infection in the mosquito vector and the mammalian host.纤维蛋白溶解系统促使蚊虫媒介和哺乳动物宿主发生感染。
Sci Adv. 2021 Feb 5;7(6). doi: 10.1126/sciadv.abe3362. Print 2021 Feb.
2
Traditional Chinese Nootropic Medicine Radix Polygalae and Its Active Constituent Onjisaponin B Reduce β-Amyloid Production and Improve Cognitive Impairments.传统中药远志及其活性成分远志皂苷B可减少β-淀粉样蛋白生成并改善认知障碍。
PLoS One. 2016 Mar 8;11(3):e0151147. doi: 10.1371/journal.pone.0151147. eCollection 2016.
3
Membrane microvesicles: a circulating source for fibrinolysis, new antithrombotic messengers.
膜微泡:纤溶作用的循环来源,新型抗血栓信使
Haematologica. 2013 Jul;98(7):e75-6. doi: 10.3324/haematol.2013.088948.